Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anthelminthics and Multivitamins for Severe Anemia in Pakistan
NCT00116493Phase 3Completed
- Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Start
- Apr 2004
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mebendazole and multivitamins in anemia (4 arms), sponsored by Johns Hopkins Bloomberg School of Public Health. Primary endpoint: Severe Anemia. Started Apr 2004; status: completed.
02
Drugs
mebendazolemultivitamins
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00116493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116493.